Accessing tyrosine kinase inhibitors (TKIs) for Chronic Myeloid Leukemia (CML) varies across Canadian provinces. Below is a step-by-step guide for patients in British Columbia.
British Columbia:
Consultation: Consult with your healthcare provider to discuss TKI treatment.
Prescription: A prescription will be provided for the appropriate TKI.
Coverage: The BC Cancer Agency covers certain TKIs. It’s important to confirm the coverage for your specific medication.
Application: Your physician will handle any necessary application processes.
Approval: Once approved, you can access the medication through designated pharmacies.
General Recommendations:
Stay Informed: Regularly consult with your healthcare provider to stay updated on treatment options and coverage changes.
Financial Assistance: If you encounter financial challenges, inquire about assistance programs or support services available in your province.
Support Groups: Engage with local or national CML support groups for additional resources and community support.
Drugs approved for treatment of CML at the B.C. Cancer Agency:
Scemblix (Ascinimib), Bosulif (Bosutinib), Sprycel (Dasatinib), Gleevec (Imatinib), Tasigna (Nilotinib), Iclusig (Ponatinib).
Accessing tyrosine kinase inhibitors (TKIs) for Chronic Myeloid Leukemia (CML) varies across Canadian provinces. Below is a step-by-step guide for patients in British Columbia.
British Columbia:
Consultation: Consult with your healthcare provider to discuss TKI treatment.
Prescription: A prescription will be provided for the appropriate TKI.
Coverage: The BC Cancer Agency covers certain TKIs. It’s important to confirm the coverage for your specific medication.
Application: Your physician will handle any necessary application processes.
Approval: Once approved, you can access the medication through designated pharmacies.
General Recommendations:
Stay Informed: Regularly consult with your healthcare provider to stay updated on treatment options and coverage changes.
Financial Assistance: If you encounter financial challenges, inquire about assistance programs or support services available in your province.
Support Groups: Engage with local or national CML support groups for additional resources and community support.
Drugs approved for treatment of CML at the B.C. Cancer Agency:
Scemblix (Ascinimib), Bosulif (Bosutinib), Sprycel (Dasatinib), Gleevec (Imatinib), Tasigna (Nilotinib), Iclusig (Ponatinib).
